Ovid Therapeutics (OVID) Other Gross PP&E Adjustments (2020 - 2025)
Historic Other Gross PP&E Adjustments for Ovid Therapeutics (OVID) over the last 6 years, with Q3 2025 value amounting to -$10.4 million.
- Ovid Therapeutics' Other Gross PP&E Adjustments rose 1024.47% to -$10.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.4 million, marking a year-over-year increase of 1024.47%. This contributed to the annual value of -$16.8 million for FY2024, which is 1464.51% up from last year.
- As of Q3 2025, Ovid Therapeutics' Other Gross PP&E Adjustments stood at -$10.4 million, which was up 1024.47% from -$10.7 million recorded in Q2 2025.
- Ovid Therapeutics' 5-year Other Gross PP&E Adjustments high stood at -$1.2 million for Q3 2021, and its period low was -$19.7 million during Q4 2023.
- Its 5-year average for Other Gross PP&E Adjustments is -$11.8 million, with a median of -$12.1 million in 2024.
- In the last 5 years, Ovid Therapeutics' Other Gross PP&E Adjustments soared by 4406.37% in 2021 and then plummeted by 110142.05% in 2022.
- Over the past 5 years, Ovid Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at -$4.2 million in 2021, then plummeted by 330.06% to -$17.9 million in 2022, then decreased by 10.03% to -$19.7 million in 2023, then rose by 14.65% to -$16.8 million in 2024, then surged by 38.19% to -$10.4 million in 2025.
- Its last three reported values are -$10.4 million in Q3 2025, -$10.7 million for Q2 2025, and -$11.0 million during Q1 2025.